Newsroom

Sorted by: Latest

-

Barilla startet weltweiten Aufruf für Start-ups im Rahmen von Good Food Makers 2026

PARMA, Italien--(BUSINESS WIRE)--Die Barilla Group hat die Bewerbungsphase für die Ausgabe 2026 von „Good Food Makers“ eröffnet, ihrem globalen Open-Innovation-Programm, das darauf abzielt, gemeinsam mit Start-ups und Innovatoren neue innovative Lösungen zu entwickeln und in realen industriellen Umgebungen zu testen. Seit seinem Start im Jahr 2019 hat das Programm mehr als 1.100 Start-ups aus über 50 Ländern einbezogen, was zu 26 Pilotprojekten geführt hat; dank der von den Alumni des Programms...
-

Samenvatting: TFG-001, een nieuwe 3D neurale microweefsel-celtherapie, bewijst een uitstekende werking en staat in voor herbezenuwing bij de ziekte van Parkinson

BORDEAUX, Frankrijk--(BUSINESS WIRE)--TreeFrog Therapeutics, een biotech-bedrijf gericht op regeneratieve geneeskunde dat celtherapieën van de nieuwe generatie ontwikkelt, maakte vandaag bekend dat het bedrijf nieuwe preklinische gegevens over TFG-001 zal voorstellen tijdens de 7e World Parkinson’s Conference. TFG-001, een 3D neurale microweefsel-celtherapie, bewees snelle afgifte van dopamine en uitgebreide herbezenuwing afkomstig van transplantaten bij verschillende translationele modellen va...
-

Riassunto: TFG-001, l'innovativa terapia cellulare basata su microtessuti neurali 3D, dimostra capacità funzionali e di reinnervazione superiori nel Parkinson

BORDEAUX, Francia--(BUSINESS WIRE)--TreeFrog Therapeutics, biotech specializzata nella medicina rigenerativa e nello sviluppo di terapie cellulari di prossima generazione, oggi ha annunciato che presenterà nuovi dati preclinici su TFG-001 alla 7a conferenza mondiale sulla malattia di Parkinson. TFG-001 è una terapia cellulare basata su microtessuti neurali 3D che ha dimostrato un rilascio rapido di dopamina e un'estesa reinnervazione a seguito di graft in diversi modelli traslazionali della mal...
-

Resumen: TFG-001, una novedosa terapia celular basada en microtejidos neuronales tridimensionales, demuestra una funcionalidad y una reinervación superiores en el tratamiento de la enfermedad de Parkinson

BURDEOS, Francia--(BUSINESS WIRE)--TreeFrog Therapeutics, una empresa biotecnológica dedicada a la medicina regenerativa que desarrolla terapias celulares de última generación, ha anunciado hoy que presentará nuevos datos preclínicos sobre el TFG-001 en la 7.ª World Parkinson's Conference. TFG-001, una terapia celular basada en microtejidos neuronales 3D, ha demostrado una rápida liberación de dopamina y una reinervación extensa derivada del injerto en múltiples modelos traslacionales avanzados...
-

Havas Reports the Progress of Transactions Under Its Current Share Buyback Program

PARIS--(BUSINESS WIRE)--Havas reports the progress of transactions under its current share buyback program...
-

JEOL: Sales Launch of the Laser SEM System “LazEdge”

TOKYO--(BUSINESS WIRE)--JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-qu...
-

Striking workers to rally outside state of the province address by Premier Houston

HALIFAX, NS--(BUSINESS WIRE)--Striking long term care workers from across Nova Scotia will be collapsing picket lines and converging outside of Premier Tim Houston’s state of the province address today. All Canadian Union of Public Employees (CUPE) members in Nova Scotia, community and political allies, as well as labour leaders will be speaking to the ‘state of long term care’ at a rally this afternoon. "It’s time our elected representatives listened to their constituents. We’re not just worke...
-

3D Investment Submits Shareholder Proposals to NS Solutions Regarding Deposits with the Parent Company and Publishes Presentation Materials for Shareholders

TOKYO--(BUSINESS WIRE)--3D Investment Partners Pte. Ltd. (hereinafter the “3D” or “the Company”), which provides discretionary investment management services to a fund that is the largest minority shareholder of NS Solutions Corporation (2327.T, hereinafter “NSSOL”), submitted shareholder proposals in April 2026 for NSSOL's 46th Annual General Meeting of Shareholders (hereinafter the “AGM”). Furthermore, today we have published presentation materials for shareholders (hereinafter the “Presentat...
-

TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease

BORDEAUX, France--(BUSINESS WIRE)--TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. Th...
-

PPG 发布2025年度可持续发展报告:可持续产品销售创新高,减排目标超预期推进

匹兹堡--(BUSINESS WIRE)--(美国商业资讯)-- PPG(纽约证券交易所代码:PPG)今日发布了《2025年度可持续发展报告》,展示了公司在实现2030年可持续发展目标方面取得的进一步进展。主要亮点包括:受客户需求拉动,可持续优势产品的销售额实现强劲增长;运营及价值链中的温室气体排放量持续降低;以及在创新、企业文化与社区责任方面的持续投入。 “可持续发展是我们企业增长战略的核心要素,也是提升客户生产力的关键驱动力。”PPG全球可持续发展副总裁Peter Votruba‑Drzal表示,“将可持续发展理念融入我们的创新与运营方式,我们正通过高效能、高效益的解决方案为客户创造可衡量的价值,同时巩固自身的竞争地位,并加速推进2030年承诺的实现。” 在经科学碳目标倡议(SBTi)验证的目标指引下,PPG在自身运营及价值链的脱碳进程中取得了稳步进展,同时不断推进可持续优势产品组合,助力客户降低能源消耗、减少排放、节约水资源并减少废弃物。 《2025年度可持续发展报告》亮点包括: 43%的销售额来自可持续优势产品,反映出客户对既能提升生产力又能带来切实环境效益的解决方案的强劲需求...